Thoracic Research and Practice
Case report

Primary Pulmonary Malignant Fibrous Histiocytoma

1.

Department of Thoracic Surgery, Acıbadem University Atakent Hospital, İstanbul, Turkey

2.

Clinic of Chest Diseases, Haydarpaşa Training Hospital, İstanbul, Turkey

3.

Department of Thoracic Surgery, Süreyyapaşa Chest Diseases and Thoracic Surgery Training Hospital, İstanbul, Turkey

4.

Clinic of Pathology, Süreyyapaşa Chest Diseases and Thoracic Surgery Training Hospital, İstanbul, Turkey

Thorac Res Pract 2017; 18: 54-56
DOI: 10.5152/TurkThoracJ.2017.16039
Read: 1673 Downloads: 707 Published: 18 July 2019

Abstract

Malignant fibrous histiocytoma (MFH) cases are classified within the group of nonclassified sarcomas. The etiopathogenesis is unclear; however, MFH commonly develops in scar tissue and in areas exposed to radiation. MFH is the most common soft tissue sarcoma in adults and may be borne in the lungs, chest wall, mediastinum, or other tissues. Primary MFH of the lung constitutes less than 0.2% of all pulmonary neoplasms; thus, an optimal treatment strategy has not yet been elucidated. We aimed to report a case of MFH of the lung with subsequent treatment administration.

Files
EISSN 2979-9139